Posted inTop Trumps

Top Trumps: Healthcare – 12 December 2024

This week, FSA provides a quick comparison of two healthcare funds: the BNP Paribas Healthcare Innovators fund and the Schroder ISF Healthcare Innovation fund.
Source: FE Fundinfo. All relevant fund data converted to US dollars for comparative purposes. Performance, alpha and volatility are annualised over three years with data as reported at the end of last month. Information ratio (IR) aims to measure a portfolio manager’s consistent ability to generate excess returns relative to a benchmark. The higher the IR, the more consistent the manager is.

Based on the popular 80s card game, each week we select an asset class and use FE fundinfo data to compare two funds based on their three-year performance, assets under management, alpha, volatility, ongoing charges and information ratio to decide which is the Top Trump.

This week, the BNP Paribas Healthcare Innovators fund defeats the Schroder ISF Healthcare Innovation fund 5-1.

BNP Paribas Healthcare Innovators fund

The fund invests in healthcare companies, primarily domiciled in the United States.

Country allocation:

  1. United States (71%)
  2. United Kingdom (7.7%)
  3. France (5%)
  4. Denmark (4.7%)
  5. Switzerland (3.6%)
  6. Belgium (3.4%)
  7. Japan (2.7%)
  8. Canada (0.7%)
  9. Forex contracts (0.1%)
  10. Cash (1.3%)

Schroder ISF Healthcare Innovation fund

The fund aims to provide capital growth by investing in equity and equity related securities of healthcare and medical related companies worldwide which meet the investment manager’s sustainability criteria.

Country allocation:

  1. United States (64.4%)
  2. Switzerland (7%)
  3. United Kingdom (5.3%)
  4. Denmark (5.2%)
  5. Liquid Assets (4.9%)
  6. Germany (3%)
  7. France (2.9%)
  8. Sweden (2.5%)
  9. Belgium (2.4%)
  10. Hong Kong (0.7%)

Part of the Mark Allen Group.